Novo Nordisk has found a buyer for cell therapy technologies dropped in its retreat from the modality. Aspect Biosystems has ...

The chief executive of Denmark’s BioInnovation Institute says a record grant from the Novo Nordisk Foundation will allow it ...

Novo Nordisk Foundation grants DKK 5.5 billion to elevate innovation in Denmark and Europe ...

The Novo Nordisk Foundation has allocated up to 736m euros in funding to BioInnovation Institute (BII), a leading institute ...

Why economic leverage beats military pressure on Greenland, and how Denmark’s exposure through Novo Nordisk makes trade tools ...

Roughly 30–50 percent by volume—come from Denmark. That makes the U.S. effectively dependent on Danish production for a ...

The Novo Nordisk Foundation is investing 5.5 billion Danish kroner ($860 million) in the BioInnovation Institute (BII) to help scale up more homegrown biotechs and deep tech companies. | The Novo ...

Jan 20 (Reuters) - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have ...

With attention in biotech focused on the JPM Healthcare conference in the US, the Novo Nordisk Foundation (NNF) has flown the ...

(Bloomberg) -- A rebound in Denmark’s pharmaceutical industry, dominated by Novo Nordisk A/S, powered the economy to its fastest quarterly expansion in almost four years. Gross domestic product rose 2 ...

COPENHAGEN, Jan 5 (Reuters) - Denmark's Novo Nordisk will offer its 1.5 and 4 milligram Wegovy weightloss pills at $149 per month to self-paying patients in the United States from January 5, it said ...

Aspect will acquire rights from Novo Nordisk to stem cell-derived islet cell and hypoimmune cell engineering technologies.